BofA lowered the firm’s price target on Tempus AI (TEM) to $48 from $60 and keeps a Neutral rating on the shares. Sentiment for Life Sciences ...

SAN DIEGO and CHICAGO, April 15, 2025 /PRNewswire/ -- Illumina Inc. (NASDAQ: ILMN) and Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine ...

NASDAQ:TEM opened at $42.12 on Thursday. The stock’s 50 day moving average price is $56.19 and its two-hundred day moving average price is $50.92. Tempus AI has a 12-month low of $22.89 and a 12 ...

(RTTNews) - Illumina Inc. (ILMN) and Tempus AI, Inc. (TEM), Tuesday announced a collaboration to accelerate clinical adoption of next-generation sequencing tests through novel evidence generation.

Illumina is teaming up with Tempus AI for a project aimed at promoting the use of DNA sequencing tests across all major areas of disease. The companies said they will work together to train ...

Assess today's live Tempus AI Inc (TEM) share price, performance and insights using our live NASDAQ: TEM stock exchange data. Analyse the historical data and Tempus AI Inc share price performance ...

SAN DIEGO and CHICAGO - Illumina Inc. (NASDAQ: ILMN) and Tempus AI, Inc. (NASDAQ: TEM) today announced a partnership aimed at advancing the use of artificial intelligence (AI) in genomic ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...